Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[G-DRG version 2007: a short overview].

Marcel L Müller1, Andrea Forschner, Thomas A Luger

  • 1Universitäts-Hautklinik, Universitätsklinikum Freiburg, Freiburg, Germany. marcel.mueller@uniklinik-freiburg.de

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|September 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Nature communications·2026
Same author

Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study.

The oncologist·2026
Same author

Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

British journal of cancer·2026
Same author

Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma.

International journal of cancer·2026
Same author

Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

The different face of skin-rash induced by brentuximab vedotin.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Repositioning Non-Ablative Fractional Lasers - Molecular and Histological Insights from a scoping review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Infusion-site reactions to foslevodopa/foscarbidopa in Parkinson's disease.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Tranexamic Acid-Soaked Intranasal Packing for Postoperative Bleeding After Nasal Interpolation Flap Repair.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Monoclonal gammopathy of dermatological significance: non-amyloid paraprotein deposits with light and heavy chains.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Papular epidermal nevus with "skyline" basal cell layer: Clinical clues from a three-member family.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
See all related articles

The German Diagnosis Related Groups (G-DRG) system saw increased complexity and differentiation in 2007, with new procedure-based payments for expensive medications. However, these changes minimally impacted dermatology, potentially leading to lower cost weights in the field.

Area of Science:

  • Healthcare economics
  • Medical billing and reimbursement
  • Health services research

Context:

  • The German health care system's structure and regulations for the 2007 version of the German Diagnosis Related Groups (G-DRG) were agreed upon by national self-governing bodies.
  • While the G-DRG system demonstrates adaptability, challenges persist in highly specialized medicine and day clinic care.

Purpose:

  • To analyze the changes in the G-DRG system for 2007, focusing on their impact on healthcare economics and dermatology.
  • To evaluate the introduction of additional procedure-based payments and their effect on cost weights.

Summary:

  • The 2007 G-DRG version introduced significant complexity and differentiation, alongside new procedure-based payments for expensive agents like etanercept and itraconazole.
  • Statistical analysis comparing 2006 and 2007 cost weights in two university clinics suggests that increased G-DRG complexity may lead to lower cost weights in dermatology.

Related Experiment Videos

  • Overall, the G-DRG system expanded procedure-based payments cautiously in 2007.

    • Impact:

    • The findings highlight the evolving nature of the G-DRG system and its financial implications for healthcare providers, particularly in dermatology.
    • Understanding these changes is crucial for optimizing reimbursement strategies and managing costs within the German healthcare landscape.